Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine poured onto the dura at the end of lumbar fusion surgery for postoperative pain control
IRCT20160307026950N73Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Reduction of pain after lumbar fusion surgery, Shortening of recovery time and 1 more. Started Dec 2025; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160307026950N73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N73.